Skip to main
ASND
ASND logo

Ascendis Pharma (ASND)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Ascendis Pharma (ASND) Stock

About Ascendis Pharma (ASND)

Ascendis Pharma A/S is a biopharmaceutical company, which engages in the development of drug candidates. It specializes in its TransCon technologies to develop new therapies that address unmet medical needs. The company was founded by Jan Moller Mikkelsen, Dirk Vetter, and Harald Rau on September 21, 2006 and is headquartered in Hellerup, Denmark.
Market cap$10.31B
Today's volume29.32K
Revenue (TTM)$394.05M
Avg. daily volume500.88K
EBITDA (TTM)-$339.92M
Open$170.66
Price / earnings ratio-27.14x
Today's range$170.66 - $174.16
Debt / equity
52 week range$111.09 - $183
5 year debt / equity-113.1x
Beta (LTM)0.58x
Interest coverage-4.26x
Dividend & yield$0.00 (0.00%)
Current ratio1.04x
Ex-dividend date
Next earningsSep 2, 2025
Dividend payable date

Ascendis Pharma Stock Rating

What analysts recommend for ASND stock, on a scale from 1(buy) to 5(sell).
Buy
Strong Buy 43%
Buy 48%
Hold 10%
Sell 0%
Strong Sell 0%

Frequently Asked Questions (FAQ)

As of Jun 15, 2025, the market cap for ASND stock is $10.32B

The current P/E ratio for ASND stock is -27.14

The 52-week high for ASND stock is $183. The current ASND stock price $undefined is 100.00% below its 52-week high

The 52-week low for ASND stock is $111.09. The current ASND stock price $undefined has increased 100.00% from its 52-week low

No, the ASND stock does not pay dividends to its shareholders

The target price for ASND stock is $197.62 based on the average of what a group of analyst think ASND stock could be worth at a future date. This is not a prediction by Public.com

How to buy ASND stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in ASND stock

    Navigate to the Explore page. Then, type ASND into the search bar. When you see ASND stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased ASND stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Ascendis Pharma Stock Earnings

The value each ASND share was expected to gain vs. the value that each ASND share actually gained.

Ascendis Pharma (ASND) reported Q1 2025 earnings per share (EPS) of -$1.66, missing estimates of -$1.51 by 9.93%. In the same quarter last year, Ascendis Pharma's earnings per share (EPS) was -$2.50. Ascendis Pharma is expected to release next earnings on 09/02/2025, with an earnings per share (EPS) estimate of $0.

Buy Ascendis Pharma (ASND) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.